![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 02, 2013 11:06:19 AM
Not many years ago BIEL ran from .0040 to 12.5 cents on much less horsepower than it presently may have. Then, it was hyped on FDA promise by a hustler who had no idea of the process, funding and time required along with the stamina of investors, public or private.
And here we are, a few years later, still alive, product still works beautifully, product line increased, not one negative side-effect, ever and still waiting on the FDA and company management to get on with it and allow the American public, the biggest market, to purchase ActiPatch and ALLAY OTC.
I recall when Zantac hit the market as an Rx drug for the treatment and prevention of recurring stomach and intestinal ulcers. Hundreds of millions spent on that approval, I knew someone in the pharma space who was involved. Now it is an antacid for indigestion, taken by the handful, much like candy. Nothing I know to do with BIEL, but an example of the absurdity.
Based on the BIEL products, the market here in the US and the drug-free aspects, I am optimistic this thing will blow through .0090 gaining momentum. Why not? And, if it does get regulatory traction, it will fly here and overseas with the dozens of distributors in place. FDA approval means something special globally.
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM